Global Patent Index - EP 1311548 A4

EP 1311548 A4 20050119 - T CELL BINDING LIGAND PEPTIDES, PEPTIDE CONSTRUCTS CONTAINING SAME AND USE THEREOF FOR TREATMENT OF IMMUNOLOGICAL DISORDERS

Title (en)

T CELL BINDING LIGAND PEPTIDES, PEPTIDE CONSTRUCTS CONTAINING SAME AND USE THEREOF FOR TREATMENT OF IMMUNOLOGICAL DISORDERS

Title (de)

T-ZELL-BINDENDE LIGANDENPEPTIDE, PEPTIDKONSTRUKTE DIE DIESE ENTHALTEN UND DEREN VERWENDUNG ZUR BEHANDLUNGEN VON IMMUNOLOGISCHEN STÖRUNGEN

Title (fr)

PEPTIDES LIGANDS DE FIXATION DE LYMPHOCYTES T, CONSTRUCTIONS PEPTIDIQUES CONTENANT CES PEPTIDES ET LEUR UTILISATION DANS LE TRAITEMENT DE TROUBLES IMMUNOLOGIQUES

Publication

EP 1311548 A4 20050119 (EN)

Application

EP 01939376 A 20010524

Priority

  • US 0116793 W 20010524
  • US 20654800 P 20000524

IPC 1-7

C07K 16/00; C07K 14/16; A61K 39/00; A61K 39/21; A61K 39/39; A61P 31/18; A61P 37/04; C07K 7/08; C07K 14/00; C07K 19/00; C12N 15/00; C12P 21/08

IPC 8 full level

A61K 39/00 (2006.01); A61K 39/21 (2006.01); A61K 39/39 (2006.01); A61P 31/18 (2006.01); A61P 37/02 (2006.01); A61P 37/04 (2006.01); C07K 7/08 (2006.01); C07K 14/16 (2006.01); C07K 14/725 (2006.01); C07K 19/00 (2006.01)

CPC (source: EP US)

A61P 31/18 (2018.01 - EP); A61P 37/02 (2018.01 - EP); A61P 37/04 (2018.01 - EP); C07K 14/005 (2013.01 - EP); A61K 39/00 (2013.01 - EP US); C12N 2740/16222 (2013.01 - EP); Y02A 50/30 (2018.01 - EP)

Citation (search report)

  • [Y] WO 9806429 A1 19980219 - VIRAL TECHNOLOGIES INC [US], et al
  • [A] WO 9806416 A1 19980219 - CEL SCI CORP [US], et al
  • [E] WO 0136448 A2 20010525 - CEL SCI CORP [US], et al
  • [XY] PISAREV V M ET AL: "Enhanced immunogenicity of an HIV gag peptide by conjugation to MHCIIbeta2 or IL-1beta epitopes is augmented, with type 1 T-cell responses, by Flt3 ligand", FASEB JOURNAL, vol. 14, no. 6, 20 April 2000 (2000-04-20), & JOINT ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS AND THE CLINICAL IMMUNOLOGY SOCIET; SEATTLE, WASHINGTON, USA; MAY 12-16, 2000, pages A943, XP009040567, ISSN: 0892-6638
  • [XY] WANG R ET AL: "Protective immunity against malaria by immunization with PYSSP2 CD4+ T helper epitope conjugated to MHC class II binding ligand MHC-II beta-chain peptide 135-149", AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, vol. 62, no. 3 Supplement, March 2000 (2000-03-01), & 49TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE; HOUSTON, TEXAS, USA; OCTOBER 29-NOVEMBER 02, 2000, pages 331 - 332, XP009040577, ISSN: 0002-9637
  • [T] CHAROENVIT Y ET AL: "CEL-1000-a peptide with adjuvant activity for Th1 immune responses", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 22, no. 19, 23 June 2004 (2004-06-23), pages 2368 - 2373, XP004515451, ISSN: 0264-410X
  • [T] ZIMMERMAN D H ET AL: "Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1SF2 p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 19, no. 32, 14 September 2001 (2001-09-14), pages 4750 - 4759, XP004303170, ISSN: 0264-410X

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0189286 A2 20011129; AU 6490201 A 20011203; EP 1311548 A1 20030521; EP 1311548 A4 20050119; JP 2003533542 A 20031111

DOCDB simple family (application)

US 0116793 W 20010524; AU 6490201 A 20010524; EP 01939376 A 20010524; JP 2001585542 A 20010524